as 02-11-2025 3:37pm EST
Guardant Health, Inc, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company offers Guardant360 LDT, a liquid biopsy test for treatment selection in advanced stage cancer, Guardant360 CDx, an FDA-approved companion diagnostic for several targeted therapies, and Guardant OMNI, a broader gene panel for immuno-oncology research. In 2021, Guardant launched Reveal, a tumor-agnostic molecular residual disease, or MRD, test. In 2022, the company launched a lab-developed test version of Shield, a liquid biopsy for colorectal cancer, or CRC, screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.
Founded: | 2011 | Country: | United States |
Employees: | N/A | City: | PALO ALTO |
Market Cap: | 6.1B | IPO Year: | 2018 |
Target Price: | $42.57 | AVG Volume (30 days): | 2.5M |
Analyst Decision: | Strong Buy | Number of Analysts: | 15 |
Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
EPS: | -4.22 | EPS Growth: | N/A |
52 Week Low/High: | $15.81 - $50.89 | Next Earning Date: | 02-20-2025 |
Revenue: | $692,256,000 | Revenue Growth: | 29.20% |
Revenue Growth (this year): | 33.18% | Revenue Growth (next year): | 16.41% |
Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
---|---|---|---|---|---|---|---|---|---|
Tariq Musa | GH | Director | Jan 17 '25 | Sell | $37.58 | 116 | $4,359.28 | 2,944 | |
Tariq Musa | GH | Director | Dec 18 '24 | Sell | $34.85 | 116 | $4,042.60 | 2,944 | |
Tariq Musa | GH | Director | Dec 13 '24 | Sell | $35.00 | 2,320 | $81,200.00 | 2,944 | |
Joyce Meghan V. | GH | Director | Dec 2 '24 | Sell | $35.90 | 100 | $3,590.00 | 7,548 | |
Kalia Kumud | GH | Chief Information Officer | Nov 18 '24 | Sell | $29.25 | 7,000 | $204,722.00 | 17,744 |
GH Breaking Stock News: Dive into GH Ticker-Specific Updates for Smart Investing
Business Wire
2 days ago
MT Newswires
5 days ago
Business Wire
5 days ago
Zacks
6 days ago
Insider Monkey
10 days ago
Business Wire
13 days ago
MT Newswires
13 days ago
Zacks
13 days ago
The information presented on this page, "GH Guardant Health Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.